Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

18,330.0000 JPY 260.0000 1.44%

As of 01:00:00 ET on 01/30/2015.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 18,260.0000 High - Low: 18,500.0000 - 18,250.0000 Primary Exchange: Tokyo
Volume: 4,214 52-Week Range: 13,840.0000 - 18,500.0000 Beta vs TP17PHRM: 0.9394

ETF Chart for 1621

No chart data available.
  • 1621:JP 18,360.0000
  • 1D
  • 1M
  • 1Y
18,070.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2015-01-30) 18,206.9000
Assets (M) (on 2015-01-30) 756.0000
Shares out (M) 0.04
Market Cap (M) 761.04
% Premium 0.68
Average 52-Week % Premium -0.0313
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 5.82%

Performance for 1621

1-Month +11.43% 1-Year +33.87%
3-Month +16.01% 3-Year +29.22%
Year To Date +11.43% 5-Year +15.36%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 12/30/2014
Name Position Value % of Total
Astellas Pharma Inc 87,600 147,737,400 21.737%
Takeda Pharmaceutical Co Ltd 28,800 143,899,200 21.172%
Otsuka Holdings Co Ltd 15,300 55,340,100 8.142%
Eisai Co Ltd 10,100 47,187,200 6.943%
Daiichi Sankyo Co Ltd 25,900 43,719,200 6.432%
Ono Pharmaceutical Co Ltd 3,500 37,555,000 5.525%
Shionogi & Co Ltd 12,000 37,500,000 5.517%
Chugai Pharmaceutical Co Ltd 7,700 22,822,800 3.358%
Santen Pharmaceutical Co Ltd 2,800 18,116,000 2.665%
Mitsubishi Tanabe Pharma Corp 9,000 15,930,000 2.344%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil